HHS Secretary Xavier Becerra assured House appropriators he would seek input from stakeholders before implementing a surprise billing fix, after Rep. Andy Harris (R-MD) raised concerns the department could issue an interim final rule to implement the No Surprises Act and skip gathering feedback.
NON-SUBSCRIBER OPTIONS
FREE TRIAL | NEWSSTAND
GET 30 DAYS FREE
Sign up for 30 days of no-obligation access for all the essential news during this critical time -- you'll be able to choose one of our online services as part of your trial: Inside CMS, FDA Week, Health Exchange Alert or Inside Drug Pricing.
Home
Breaking Medicaid News
CMS Revokes Trump Admin’s 10-Year Extension Of Texas 1115 Waiver
CMS Friday (April 16) revoked an 11th-hour move by the Trump administration to grant Texas a 10-year extension of its 1115 waiver that includes federal funding for the state’s uncompensated care funding pool that reimburses hospitals for caring for the uninsured.
CMS Grants Georgia's And Missouri's Postpartum Coverage Extensions
Latest Pandemic News
GOPers Want To Delay Second Vaccine Doses, Officials Say It’s Complicated
A group of GOP lawmakers wants FDA to use real-world evidence from Israel and the United Kingdom to justify extending the amount of time patients can wait between getting their first and second shots of the currently authorized two-dose mRNA COVID-19 vaccines.
-
Marks: UK Study Will Be ‘Helpful’ In Deciding If U.S. Vaccines Can Be Mixed
-
CDC Weighs Options To Minimize LTC Facilities’ Vaccine Interruptions
-
FDA Revokes EUA For Solo Use Of Lilly’s COVID-19 Antibody Bamlanivimab
-
WH Announces $1.7 Billion In Funding To Fight COVID-19 Variants
-
CDC’s ACIP Will Reconvene April 23 To Discuss Pause On J&J’s Vaccine
-
CDC Advisers Weigh Ramifications As They Punt Vote On J&J Vaccine Pause
-
States, Retailers Suspend Use Of J&J Vaccine Amid 6 Blood Clot Cases
-
Researchers Suggest Remdesivir-Ruxolitinib Drug Combo For COVID-19
Latest News
Several House Republicans said at a hearing Wednesday (April 14) that Congress should pass legislation to either extend or make permanent the Schedule 1 classification for fentanyl-related substances, while some Democrats touted an opposing bill that would use harm-reduction strategies to tackle the fentanyl crisis.
Destined for the president’s signature are two bipartisan bills that aim to boost generic and biosimilar competition by restricting eligibility for drug exclusivity and by increasing confidence in biosimilars.
The House on Wednesday (April 14) passed a bipartisan bill that will require food makers declare sesame as an allergen on their food labels. The bill, which cleared the Senate in March, now heads to the president’s desk.
FDA, HHS and the American College of Obstetricians and Gynecologists on Tuesday (April 13) filed a joint motion with the U.S. Court of Appeals for the Fourth Circuit requesting the court put a hold on ACOG’s lawsuit against FDA in light of the agency’s recent decision to temporarily lift the in-person prescribing and dispensing requirements for abortion medication mifepristone.
Rep. Kevin Brady (R-TX), ranking member and former chairman of the House Ways & Means Committee, won’t run for re-election in 2022, he said on Tuesday, announcing his 13th term will be his last.
U.S. Trade Representative Katherine Tai on Tuesday discussed with labor leaders a proposed waiver of some World Trade Organization rules on intellectual property rights for COVID-19 vaccines, USTR said in a readout.
Information blocking rules that went into effect last Monday (April 5) are causing confusion among providers due to lack of guidance from the Office of the National Coordinator for Health Information Technology, health IT stakeholders say.
© 2002-2021. Inside Washington Publishers | Contact Us